Skip Navigation

European Heart Journal ():;
This Article
Right arrow Abstract
Right arrow FREE Full Text
Right arrow E-letters: Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions
Right arrow Disclaimer

Long-term effect of CB1 blockade with rimonabant on cardiometabolic risk factors: two year results from the RIO-Europe Study
Eur Heart J Van Gaal et al. 29: 1761

Supplementary Data

Supplementary Data

Files in this Data Supplement:



This Article
Right arrow Abstract
Right arrow FREE Full Text
Right arrow E-letters: Submit a response
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrowRequest Permissions
Right arrow Disclaimer